Alzheimer's and Parkinson's sufferers receive boost from Israeli research
OutroThe brain is the control center for most of the functions throughout the body; it is also where we experience the physical world around us and perceive our inner psychological and emotional selves. It is where thought, love and dreams are conjured up and where memory is embedded.
The rest:Monarsen will soon be poised to enter final Phase III clinical trials. If the drug continues to prove its efficacy, it will receive the essential FDA approval that permits it to enter the pharmacopoeia available to the prescribing physician. “The development of a new drug costs well over $500 million; most of the investment goes into this last phase,” says Soreq, who is optimistic that Ester Neuroscience will find a strategic partner for this potentially powerful new weapon against the misery and debilitation caused by Alzheimer’s and other inflammatory diseases such as myasthenia gravis.